Actively Recruiting
Management of COPD Patients With BoraCare® Remote Monitoring Solution Including BVS3 Early Detection Score for COPD Exacerbations
Led by Biosency · Updated on 2025-08-22
380
Participants Needed
10
Research Sites
158 weeks
Total Duration
On this page
Sponsors
B
Biosency
Lead Sponsor
A
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this clinical trial is to demonstrate the superiority of remote monitoring with the Bora Care solution in patients with COPD and frequent exacerbations (experimental group) compared to conventional follow-up alone (control group) on the total number of hospital days per patient for respiratory deterioration over 12 months of follow-up. The main question it aims to answer is: Does remote monitoring of COPD patients reduce the average annual length of hospitalization for exacerbations of COPD patients? All participants will benefit a conventional clinical follow-up. Participants in experimental group will also benefit from the Bora care remote monitoring system.
CONDITIONS
Official Title
Management of COPD Patients With BoraCare® Remote Monitoring Solution Including BVS3 Early Detection Score for COPD Exacerbations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient over 18 years of age with COPD diagnosed following SPLF guidelines and known respiratory function measured within the last 12 months
- Patient hospitalized for COPD exacerbation in the past 12 months
- Patient who has given informed consent
- Patient enrolled in a social security scheme (Art L1121-11 of the CSP)
You will not qualify if you...
- Presence of an unstable or very severe comorbidity as judged by the investigator
- Patient with psychological frailties
- Patient currently enrolled in another interventional trial
- Patient who does not speak French and cannot use the Bora Band or lacks a caregiver to assist
- Patient under guardianship or unable to provide free and informed consent
- Pregnant or nursing women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 10 locations
1
CHU de Brest
Brest, Brittany Region, France, 29200
Actively Recruiting
2
Centre Hospitalier Bretagne Atlantique
Vannes, Brittany Region, France, 56000
Actively Recruiting
3
Centre Hospitalier de Chartres
Le Coudray, Centre-Val de Loire, France, 28630
Not Yet Recruiting
4
Centre Hospitalier Verdun
Verdun, Grand Est, France, 55100
Not Yet Recruiting
5
Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL)
Lille, Hauts-de-France, France, 59000
Not Yet Recruiting
6
Clinique du Millénaire
Montpellier, Occitanie, France, 34000
Not Yet Recruiting
7
Centre Hospitalier Universitaire de Toulouse
Toulouse, Occitanie, France, 31300
Not Yet Recruiting
8
Hôpital Européen Marseille
Marseille, Provence-Alpes-Côte d'Azur Region, France, 13003
Not Yet Recruiting
9
Hôpital de la Pitié Salpêtrière - AP-HP
Paris, Île-de-France Region, France, 75013
Not Yet Recruiting
10
Hôpital Cochin - AP-HP
Paris, Île-de-France Region, France, 75014
Actively Recruiting
Research Team
A
Alexis TOULLEC
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here